Madagascar

in page functions
[French]
Madagascar
Total population (2018) 26,326,236
Birth cohort (2018) 882,432
Surviving Infants (surviving to 1 year per year, 2018) 856,746
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 50/1000
World Bank Index, IDA (2015) 3.14
Gross Nation Income (per capita US$, 2015) 420
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 114

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Madagascar

Type of support

Approvals

2001-2022 (US$)
(22 Aug 2018)

Commitments

2001-2022 (US$)
(22 Aug 2018)

Disbursements

2000-2018 (US$)
(22 Aug 2018)

% Disbursed

(22 Aug 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $186,218,469 $210,681,930 $183,704,886
Cash Support (CASHSUPP) $177,500 $177,500 $177,500 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $3,597,780 $3,597,780
Health system strengthening (HSS 1) $10,936,770 $10,936,770 $10,936,770 100%
Health system strengthening (HSS 2) $6,238,039 $16,640,000 $3,207,309 51%
HPV Demo (NVS) $247,348 $247,348 $247,348 100%
Immunisation services support (ISS) $4,064,400 $4,064,400 $4,064,400 100%
Injection Safety Devices (NVS) $496,500 $762,000 $416,160 84%
Injection safety support (INS) $615,555 $615,555 $615,555 100%
IPV (NVS) $6,848,932 $6,848,932 $4,991,299 73%
Penta (NVS) $43,099,452 $44,529,452 $43,183,065 100%
Pneumo (NVS) $76,394,916 $85,437,416 $81,687,953 107%
Rotavirus (NVS) $17,452,079 $20,775,579 $18,128,329 104%
Tetra DTP-HepB (NVS) $13,792,698 $13,792,698 $13,792,698 100%
Vaccine Introduction Grant (VIG) $2,256,500 $2,256,500 $2,256,500 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Madagascar DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2008) 72.60%
Household survey: DTP3 coverage for female (2008) 73.00%
Household survey: Last DTP3 survey (2008) 73%
% districts achieving > 80% DTP3 coverage (2017) 88%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 58%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$21,258,034 $162,446,852

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Madagascar

24 April 2015

Lions Club WIW

Lions Clubs mobilise for World Immunization Week

Advocacy toolkit launched to help Health Ministries spread the word about vaccination against measles and rubella in developing countries.

18 September 2014

Nepal IPV

Nepal becomes first country to introduce IPV with Gavi support

Nepal is one of 25 countries who have received approval to begin using IPV with Gavi support. Afghanistan and Pakistan are also planning to introduce IPV by end of next year.

23 April 2014

WIW 2014 En

GAVI Alliance to present plans to expand impact of vaccines by 2020

Drive to secure a healthy future for children in developing countries.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here